Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Euan Ramsay
Observed names:
E RAMSAY,
E Ramsay,
E. Ramsay
Institution:
Precision Nanosystems (Canada)
Observed institutions:
Centre for Drug Research and Development,
BC Cancer Agency,
University of Tasmania,
Precision Nanosystems (Canada),
Cardiff University
OpenAlex ID:
A5113658570
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
2019
·
Nidhi Jyotsana
, Amit Sharma
, et al.
·
Annals of Hematology
·
102
Examination of the biophysical interaction between plasmid DNA and the polycations, polylysine and polyornithine, as a basis for their differential gene transfection in-vitro
2000
·
Euan Ramsay
, Jon Hadgraft
, et al.
·
International Journal of Pharmaceutics
·
95
Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy
2010
·
Anitha M. Thomas
, Anita I. Kapanen
, et al.
·
Journal of Controlled Release
·
88
Microfluidics: a transformational tool for nanomedicine development and production
2016
·
Shyam Garg
, Gesine Heuck
, et al.
·
Journal of drug targeting
·
85
Polylysine and Polyornithine Gene Transfer Complexes: A Study of Complex Stability and Cellular Uptake as a Basis for their Differential in-vitro Transfection Efficiency
2002
·
E. Ramsay
, M. Gumbleton
·
Journal of drug targeting
·
74
Copper–topotecan complexation mediates drug accumulation into liposomes
2006
·
Amandeep S. Taggar
, Jehan Alnajim
, et al.
·
Journal of Controlled Release
·
72
The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations
2005
·
Euan Ramsay
, Nancy Santos
, et al.
·
Current Drug Delivery
·
61
A novel liposomal irinotecan formulation with significant anti-tumour activity: Use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention
2007
·
E RAMSAY
, Jehan Alnajim
, et al.
·
European Journal of Pharmaceutics and Biopharmaceutics
·
58
Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation
2006
·
Euan Ramsay
, Jehan Alnajim
, et al.
·
Pharmaceutical Research
·
55
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
2020
·
Sagarajit Mohanty
, Nidhi Jyotsana
, et al.
·
Cancers
·
51
PDF
Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin
2008
·
Jennifer H.E. Baker
, Jeffrey Lam
, et al.
·
Clinical Cancer Research
·
51
Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties
2010
·
Emmanuel A. Ho
, Euan Ramsay
, et al.
·
Journal of Pharmaceutical Sciences
·
46
Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers
2006
·
D. Waterhouse
, K. Gelmon
, et al.
·
Current Cancer Drug Targets
·
44
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer
2010
·
Alain G. Musende
, Andy Eberding
, et al.
·
The Prostate
·
35
RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo
2017
·
N Jyotsana
, A Sharma
, et al.
·
Leukemia
·
25
Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
2006
·
Maite Verreault
, Murray Webb
, et al.
·
Current Gene Therapy
·
21
The Role of the Transition Metal Copper and the Ionophore A23187 in the Development of Irinophore C™
2010
·
Nilesh Patankar
, Malathi Anantha
, et al.
·
Pharmaceutical Research
·
18
Irinotecan–cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line
2006
·
Jason Zastre
, Malathi Anantha
, et al.
·
Cancer Chemotherapy and Pharmacology
·
17
A Cationic Liposomal Vincristine Formulation with Improved Vincristine Retention, Extended Circulation Lifetime and Increased Anti-Tumor Activity
2007
·
Murray S. Webb
, Nancy L. Boman
, et al.
·
Letters in Drug Design & Discovery
·
5
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML
2019
·
Sagarajit Mohanty
, Nidhi Jyotsana
, et al.
·
Blood
·
4
Nanomedicines: exploring the past, present and future
2017
·
Yvonne Perrie
, Euan Ramsay
·
Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)
·
4
PDF
Effective Treatment of Human CML By RNAi In Vivo in a Xenotransplantation Mouse Model
2015
·
Nidhi Jyotsana
, Amit Sharma
, et al.
·
Blood
·
3
A novel approach to prepare a liposomal irinotecan formulations that exhibit significant therapeutic activity in vivo
2004
·
Euan Ramsay
, Jehan Alnajim
, et al.
·
Cancer Research
·
2
A Scalable Microfluidic Platform for the Development of Lipid Nanoparticles for Gene Delivery
2018
·
Jagbir Singh
, Kevin Ou
, et al.
·
Proceedings of the World Congress on Recent Advances in Nanotechnology
·
1
Microfluidic Manufacture of RNA-Lipid Nanoparticles Leads to Highly Efficient Delivery of Potent Nucleic Acid Therapeutics for Controlling Gene Expression
2016
·
Grace Tharmarajah
, Eric Ouellet
, et al.
·
Molecular Therapy
·
1
PDF
Show more works
View as search
Works count:
29
Citation count:
1,019
H-index:
17
I10-index:
18
Year
Topic
Type